CPHI Milan 2026

Clinical Testing

Clinical Testing for Precision Medicine in Drug Development

The model of drug development has traditionally been based on the onesize fits all concept whereby therapeutic measures

7 Key Considerations for Sponsors under the Revised EU Clinical Trial Framework

CTR No which was implemented on January is a major reshaping in the field of European clinical

Accelerating Rare Disease Trials through Patient-Centric Approaches

Rare diseases although individually unusual affect more than million people around the world